Cardiovascular, Thromboembolic Mortality Risk Factors in Multiple Myeloma
An analysis of SEER data identified the risk for these cardiovascular events and the common related causes of death among patients with MM.
Diagnosis & Disease Information
Association Between Multiple Myeloma With VTE and Increased Mortality at 2, 5 Years
A study presented at the 2018 ASCO Annual Meeting investigated the mortality risk for patients with multiple myeloma who develop VTE.
Platinum-Based Chemotherapies Demonstrate Similar Risk for Thromboembolic Events
Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.
No Benefit to Extensive Cancer Screening in Unprovoked Venous Thromboembolism
Although unprovoked VTE may be a sign of occult cancer, results of a meta-analysis showed no benefit to extensive cancer screening in these patients.
Tissue Factor May Predict for Recurrent VTE in Patients Receiving Anticoagulants
An evaluation of the association of tissue factor, clinical risk factors, and other biomarkers measured at the time of initial VTE with recurrent VTE helps determine their predictive value for patients at high risk.
Cancer-Associated Thrombosis: An Overview
This review examines the epidemiology and pathophysiology of cancer-associated thrombosis, risk factors, and new predictive biomarkers for venous thromboembolism (VTE).
Blood clot risk high in outpatient chemotherapy patients
The occurrence of venous thromboembolism (VTE) is greater than has been identified in clinical trials, according to a large-scale analysis that assessed the real-world risk.
Unsuspected PE Does Not Up Mortality Risk in Cancer Patients
Unsuspected PE patients also have similar risk of recurrent VTE as those with clinically suspected PE.
Semuloparin Prophylaxis Effective in Cancer Patients
Semuloparin prophylaxis reduces the incidence of thromboembolic events during chemotherapy, with no increase in major bleeding.
Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued
New guidelines for VTE apply to acute and critical patients, outpatients with cancer, and long-distance travelers.
- Loading...
Loading...
Next post in Daily Oncology News
Loading... 
Loading...